These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1336 related items for PubMed ID: 26089010

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Obesity, ultrasound indexes of fat depots and lipid goal attainment in patients with high and very high cardiovascular risk: A novel approach towards better risk reduction.
    Haberka M, Okopień B, Gąsior Z.
    Nutr Metab Cardiovasc Dis; 2016 Feb; 26(2):123-33. PubMed ID: 26830392
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ.
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [Abstract] [Full Text] [Related]

  • 9. Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice.
    Arca M, Ansell D, Averna M, Fanelli F, Gorcyca K, Iorga ŞR, Maggioni AP, Paizis G, Tomic R, Catapano AL.
    Atherosclerosis; 2018 Apr; 271():120-127. PubMed ID: 29499359
    [Abstract] [Full Text] [Related]

  • 10. Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.
    März W, Dippel FW, Theobald K, Gorcyca K, Iorga ŞR, Ansell D.
    Atherosclerosis; 2018 Jan; 268():99-107. PubMed ID: 29197254
    [Abstract] [Full Text] [Related]

  • 11. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T.
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [Abstract] [Full Text] [Related]

  • 12. Lipid-lowering therapy and lipid goal attainment in patients with metabolic syndrome in China: subgroup analysis of the Dyslipidemia International Study-China (DYSIS-China).
    Wang F, Ye P, Hu D, Min Y, Zhao S, Wang Y, Mu Y, Yan X, Li Z, Wei Y, Li J, DYSIS-China Study Investigators.
    Atherosclerosis; 2014 Nov; 237(1):99-105. PubMed ID: 25238215
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of lipid profiles and attainment of lipid goals in patients <65 years versus patients ≥65 years (from the Lipid Treatment Assessment Project [L-TAP] 2).
    Rodriguez F, Santos RD, Messig M, Tarasenko L, Ferrières J, Jukema JW, Chiang CW, Waters DD, Foody JM, L-TAP 2 Investigators.
    Am J Cardiol; 2012 Jun 15; 109(12):1738-42. PubMed ID: 22440124
    [Abstract] [Full Text] [Related]

  • 15. Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.
    Gitt AK, Drexel H, Feely J, Ferrières J, Gonzalez-Juanatey JR, Thomsen KK, Leiter LA, Lundman P, da Silva PM, Pedersen T, Wood D, Jünger C, Dellea PS, Sazonov V, Chazelle F, Kastelein JJ, DYSIS Investigators.
    Eur J Prev Cardiol; 2012 Apr 15; 19(2):221-30. PubMed ID: 21450578
    [Abstract] [Full Text] [Related]

  • 16. Association between dyslipidemia and vascular events in patients treated with statins: report from the UK General Practice Research Database.
    Sazonov V, Beetsch J, Phatak H, Wentworth C, Evans M.
    Atherosclerosis; 2010 Jan 15; 208(1):210-6. PubMed ID: 19766999
    [Abstract] [Full Text] [Related]

  • 17. Attainment of normal lipid levels among high cardiovascular risk patients: pooled analysis of observational studies from the United Kingdom, Sweden, Spain and Canada.
    Ambegaonkar BM, Bash LD, Chirovsky DR, Jameson K, Grant S, Nocea G, Pettersson B, Sazonov V.
    Eur J Intern Med; 2013 Oct 15; 24(7):656-63. PubMed ID: 23953848
    [Abstract] [Full Text] [Related]

  • 18. Prevalence and risk distribution of residual dyslipidemia in statin-treated patients in Greece.
    Liberopoulos E, Vlasserou F, Mitrogianni Z, Papageorgantas I, Elisaf M, DYSIS-GREECE Investigators.
    Angiology; 2012 Apr 15; 63(3):184-93. PubMed ID: 21676964
    [Abstract] [Full Text] [Related]

  • 19. Attainment of low-density lipoprotein cholesterol goal after endovascular treatment is associated with reduced cardiovascular events in patients with peripheral arterial disease.
    Lee JH, Ko YG, Shin DH, Kim JS, Kim BK, Choi D, Hong MK, Jang Y.
    J Vasc Surg; 2016 Mar 15; 63(3):756-63. PubMed ID: 26603545
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 67.